|
Volumn 32, Issue 3, 2001, Pages 367-370
|
Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer
|
Author keywords
Bladder neoplasms; Carcinoma; Matrix proteins; Tumor markers
|
Indexed keywords
MATRIX PROTEIN;
NUCLEAR MATRIX PROTEIN 22;
TUMOR MARKER;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
BLADDER CANCER;
BLADDER CARCINOMA;
CANCER GRADING;
CANCER STAGING;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
DISEASE MARKER;
EVALUATION;
FEMALE;
FOLLOW UP;
HEMATURIA;
HIGH RISK PATIENT;
HUMAN;
INFLAMMATION;
MAJOR CLINICAL STUDY;
MALE;
NEOPLASM;
SAMPLE;
TRANSITIONAL CELL CARCINOMA;
TUMOR DIAGNOSIS;
URINALYSIS;
ADULT;
AGED;
AGED, 80 AND OVER;
CARCINOMA, TRANSITIONAL CELL;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
NUCLEAR PROTEINS;
PROSPECTIVE STUDIES;
REFERENCE VALUES;
SENSITIVITY AND SPECIFICITY;
TUMOR MARKERS, BIOLOGICAL;
URINARY BLADDER NEOPLASMS;
|
EID: 0034855303
PISSN: 03011623
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1017509418440 Document Type: Article |
Times cited : (18)
|
References (11)
|